UMIN000048407Completed
A prospective observational study assessing patient preference for oral vs. injectable semaglutide in Japanese patients with type 2 diabetes using insulin and GLP-1 receptor agonists
Kanto Rosai HospitalUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- type 2 diabetes
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Kanto Rosai Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Jul 20, 2022
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048407
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048407 through Pure Global AI's free database. This phase not specified trial is sponsored by Kanto Rosai Hospital and is currently Completed. The study focuses on type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.